OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4093$401.0058

Toho Acetylene Co Ltd

Commodity ChemicalsVerified

Toho Acetylene maintains a strong liquidity position, with cash and equivalents amounting to ¥9.5 billion, representing 28.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of ¥826 million and total liabilities of ¥15.3 billion, indicating a liquidity buffer of 5.4%. The current ratio of 1.79 further supports short-term liquidity health. Profitability metrics show a return on equity (ROE) of 6.9% and a return on assets (ROA) of 3.76%, which are below the industry median for Commodity Chemicals. The company's gross margin is 31.5% (¥10.97 billion gross profit on ¥34.8 billion revenue), but operating margin is 5.4% (¥1.89 billion operating income), indicating pressure from operating expenses. Net margin is 3.6% (¥1.26 billion net income), which is in line with the sector's lower end. The company's revenue is distributed across four segments: Gas Related (primary), Appliances and Equipment, Automotive Equipment Related, and Other. The Gas Related segment is the largest contributor, though specific revenue shares are not disclosed. Geographically, the company is concentrated in Japan, with no material international revenue disclosed in the latest financials. Outlook for the current fiscal year shows a revenue growth of 2.1% year-over-year, with a net income growth of 1.8%. Capital expenditure is expected to remain negative, indicating asset optimization rather than expansion. The next fiscal year is projected to see a 1.5% revenue increase and a 2.3% net income increase, suggesting a modest but stable growth trajectory. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.21 is well below the industry median, and the company has not issued new shares in the past 12 months. No dilution sources were identified in the latest filings, and the dilution potential remains low. Recent events include the publication of the latest annual report, which disclosed no material changes in business strategy or regulatory exposure. The company has not issued any new debt or equity in the past 12 months, and no significant legal or regulatory actions are reported in the latest filings.

30-day price · 4093-72.00 (-16.0%)
Low$369.00High$459.00Close$378.00As of21 May, 00:00 UTC
Profile
CompanyToho Acetylene Co Ltd
Ticker4093.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Toho Acetylene Co., Ltd. is a Japan-based company engaged in the manufacture and sale of high-pressure gases, and the purchase and sale of appliances and equipment, operating through four business segments.

Classification. Toho Acetylene is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.

Toho Acetylene maintains a strong liquidity position, with cash and equivalents amounting to ¥9.5 billion, representing 28.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of ¥826 million and total liabilities of ¥15.3 billion, indicating a liquidity buffer of 5.4%. The current ratio of 1.79 further supports short-term liquidity health. Profitability metrics show a return on equity (ROE) of 6.9% and a return on assets (ROA) of 3.76%, which are below the industry median for Commodity Chemicals. The company's gross margin is 31.5% (¥10.97 billion gross profit on ¥34.8 billion revenue), but operating margin is 5.4% (¥1.89 billion operating income), indicating pressure from operating expenses. Net margin is 3.6% (¥1.26 billion net income), which is in line with the sector's lower end. The company's revenue is distributed across four segments: Gas Related (primary), Appliances and Equipment, Automotive Equipment Related, and Other. The Gas Related segment is the largest contributor, though specific revenue shares are not disclosed. Geographically, the company is concentrated in Japan, with no material international revenue disclosed in the latest financials. Outlook for the current fiscal year shows a revenue growth of 2.1% year-over-year, with a net income growth of 1.8%. Capital expenditure is expected to remain negative, indicating asset optimization rather than expansion. The next fiscal year is projected to see a 1.5% revenue increase and a 2.3% net income increase, suggesting a modest but stable growth trajectory. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.21 is well below the industry median, and the company has not issued new shares in the past 12 months. No dilution sources were identified in the latest filings, and the dilution potential remains low. Recent events include the publication of the latest annual report, which disclosed no material changes in business strategy or regulatory exposure. The company has not issued any new debt or equity in the past 12 months, and no significant legal or regulatory actions are reported in the latest filings.
Key takeaways
  • Toho Acetylene maintains a strong liquidity position with ¥9.5 billion in cash and equivalents.
  • The company's ROE of 6.9% is below the industry median, indicating room for improvement in capital efficiency.
  • Revenue is concentrated in Japan, with no material international exposure disclosed.
  • Outlook for the next fiscal year shows modest revenue and net income growth, with no significant capital expenditure.
  • Low liquidity and dilution risk, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$34.80B
Gross profit$10.97B
Operating income$1.89B
Net income$1.26B
R&D
SG&A
D&A
SBC
Operating cash flow$2.23B
CapEx-$777.5M
Free cash flow$825.9M
Total assets$33.64B
Total liabilities$15.34B
Total equity$18.30B
Cash & equivalents$9.50B
Long-term debt$3.84B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$401.00
Market cap$13.95B
Enterprise value$8.29B
P/E11.0
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income4.4
EV/OCF3.7
P/B0.8
P/Tangible book0.8
Tangible book$18.30B
Net cash$5.66B
Current ratio1.8
Debt/Equity0.2
ROA3.8%
ROE6.9%
Cash conversion1.8%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4093Activity
Op margin5.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin31.5%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity21.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS37.03 JPY
Last actual revenue34,804,370,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:47 UTC#22b71735
Market quoteclose JPY 401.00 · shares 0.03B diluted
no public URL
2026-05-10 09:47 UTC#fc6832c1
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:49 UTCJob: a16f0ab4